Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 26:2019:6054694.
doi: 10.1155/2019/6054694. eCollection 2019.

Phenotypic Characterization and Antibiotic Resistance Patterns of Extended-Spectrum β-Lactamase- and AmpC β-Lactamase-Producing Gram-Negative Bacteria in a Referral Hospital, Saudi Arabia

Mutasim E Ibrahim  1 , Mohammed Abbas  2 , Abdullah M Al-Shahrai  3 , Bahaeldin K Elamin  1   4
Affiliations

Phenotypic Characterization and Antibiotic Resistance Patterns of Extended-Spectrum β-Lactamase- and AmpC β-Lactamase-Producing Gram-Negative Bacteria in a Referral Hospital, Saudi Arabia

Mutasim E Ibrahim et al. Can J Infect Dis Med Microbiol. .

Abstract

Background: Emergence of pathogenic bacteria carrying β-lactamase-resistant determinants has become a major health problem in the hospital setting. The study aimed to determine antibiotic-resistant patterns and frequency of extended-spectrum β-lactamase- (ESBL-) producing Gram-negative bacteria (GNB) and AmpC β-lactamase-producing GNB.

Methodology: A prospective cross-sectional study was conducted during a period from September 2017 to August 2018 at King Abdullah Hospital, Bisha Province, Saudi Arabia. GNB (n = 311) were recovered from patients' clinical specimens including sputum, urine, wound pus, blood, tracheal aspirates and high vaginal swabs, umbilical discharge, eye discharge, and cerebrospinal fluids. Isolates were identified by the Phoenix identification system. Antimicrobial susceptibility was tested by the Kirby-Bauer disk procedure. Phenotypic characterization of ESBLs and AmpC β-lactamases was performed utilizing the double-disk synergy test and inhibitor-based method, respectively. Associations with outcome measures were determined by simple descriptive statistics and a chi-square test.

Results: Out of 311 GNB isolates, the frequency of ESBL and AmpC β-lactamase producers was 84 (27%) and 101 (32.5%), respectively. Klebsiella pneumoniae and Escherichia coli were common ESBL producers. AmpC β-lactamases predominate among Acinetobacter spp. and Pseudomonas aeruginosa. Coproduction of ESBLs and AmpC β-lactamases was found in 36 (11.6%) isolates, with very close relative frequencies among K. pneumoniae, Acinetobacter spp., and P. aeruginosa. β-Lactamase producers were predominantly found in the surgical department (56.5%) and ICUs (44.2%). ESBL producers revealed high resistance for cefuroxime (96.4%), cefotaxime (92.9%), and trimethoprim/sulfamethoxazole (90.5%). The resistance rates were significantly higher among ESBL producers than nonproducers for cephalosporins (p < 0.001), amoxicillin/clavulanate (p < 0.001), piperacillin/tazobactam (p = 0.010), nitrofurantoin (p = 0.027), aztreonam (p < 0.001), ciprofloxacin (p = 0.002), and trimethoprim/sulfamethoxazole (p < 0.001). Significantly higher (p < 0.05) resistance rates were observed among AmpC β-lactamase producers than nonproducers for all tested antibiotics.

Conclusions: This finding showed a high prevalence of ESBL- and AmpC β-lactamase-producing GNB in our hospital. Quality control practice and routine detection of β-lactamase producers before deciding on antibiotic therapy are advocated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency of ESBLs and AmpC β-lactamases, among different Gram-negative pathogens collected from patients at King Abdullah Hospital, Bisha, Saudi Arabia. ∗Morganella morganii (n = 5), Klebsiella oxytoca (n = 4), Serratia marcescens (n = 4), Providencia rettgeri (n = 4), Citrobacter freundii (n = 3), Salmonella enterica (n = 2), and Proteus vulgaris (n = 1).
Figure 2
Figure 2
Distribution of different Gram-negative pathogens producing ESBLs (n = 84) (a) and AmpC β-lactamases (n = 101) (b) among hospital departments. High frequency of ESBLs and AmpC β-lactamases was shown among K. pneumoniae and Acinetobacter spp., respectively.
See this image and copyright information in PMC

References

    1. Marie M. A., John J., Krishnappa L. G., Gopalkrishnan S. Molecular characterization of the β-lactamases in Escherichia coli and Klebsiella pneumoniae from a tertiary care hospital in Riyadh, Saudi Arabia. Microbiology and Immunology. 2013;57(12):805–810. doi: 10.1111/1348-0421.12104. - DOI - PubMed
    1. Trecarichi E. M., Cauda R., Tumbarello M. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections. Future Microbiology. 2012;7(10):1173–1189. doi: 10.2217/fmb.12.100. - DOI - PubMed
    1. Maraskolhe D. L., Deotale V. S., Mendiratta D. K., Narang P. Comparision of three laboratory tests for detection of Ampc β lactamases in Klebsiella species and E. Coli. Journal of Clinical and Diagnostic Research. 2014;8:5–8. doi: 10.7860/JCDR/2014/8256.4432. - DOI - PMC - PubMed
    1. Andrew B., Kagirita A., Bazira J. Prevalence of extended-spectrum beta-lactamases-producing microorganisms in patients admitted at KRRH, southwestern Uganda. International Journal of Microbiology. 2017;2017:5. doi: 10.1155/2017/3183076.3183076 - DOI - PMC - PubMed
    1. Teethaisong Y., Eumkeb G., Chumnarnsilpa S., et al. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods. Journal of Medical Microbiology. 2016;65(10):1079–1087. doi: 10.1099/jmm.0.000326. - DOI - PubMed

LinkOut - more resources